Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-10-26

FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approves a supplemental application for ATORVASTATIN CALCIUM from Mylan Pharmaceuticals Inc., granting approval of a generic atorvastatin product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ATORVASTATIN CALCIUM (atorvastatin calcium)

Snippet

SUPPL AP for ATORVASTATIN CALCIUM (ATORVASTATIN CALCIUM)